Coronary Artery Atherosclerosis in Hypertensive Patients: The Role of Fibrinogen Genetic Variability

2017 ◽  
Vol 70 (1) ◽  
pp. 34-41 ◽  
Author(s):  
Nikolaos Papageorgiou ◽  
Alexandros Briasoulis ◽  
Georgios Hatzis ◽  
Emmanuel Androulakis ◽  
Maria Kozanitou ◽  
...  
2007 ◽  
Vol 7 (Suppl 1) ◽  
pp. 25???29 ◽  
Author(s):  
George L Bakris ◽  
Rhonda M Cooper-DeHoff ◽  
Qian Zhou ◽  
Stuart Kupfer ◽  
Annette Champion ◽  
...  

2015 ◽  
Vol 87 (9) ◽  
pp. 106 ◽  
Author(s):  
F. Yu. Kopylov ◽  
A. A. Bykova ◽  
Yu. V. Vasilevsky ◽  
S. S. Simakov

2016 ◽  
Vol 88 (9) ◽  
pp. 31-38 ◽  
Author(s):  
O I Afanasievа ◽  
E A Pylaeva ◽  
E A Klesareva ◽  
A V Potekhina ◽  
S I Provatorov ◽  
...  

Aim. To study the role of lipoprotein(a) [Lp(a)] as a potential autoantigen causing the activation of immunocompetent cells in atherosclerosis. Subjects and methods. A total of 104 men with stable coronary artery (CA) disease and different degrees of progressive coronary atherosclerosis were examined. Clinical blood analysis was carried out and lymphocyte subpopulations (CD4+, Th1, Th17, and Treg) were determined using immunofluorescence and flow cytometry. In addition, the indicators of blood lipid composition, Lp(a), autoantibody (autoAb) titer to Lp(a), and low-density lipoproteins (LDL), and the lymphocyte activation marker sCD25 were also measured. Results. The Lp(a) level was shown to predict the severity of CA lesions (β=0.28, p


2004 ◽  
Vol 22 (Suppl. 2) ◽  
pp. S74
Author(s):  
B. Gigante ◽  
G. Iaccarino ◽  
C. Morisco ◽  
S. Verdoliva ◽  
R. Visconti ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
I Leontsinis ◽  
C Tsioufis ◽  
K Dimitriadis ◽  
A Kasiakogias ◽  
I Liatakis ◽  
...  

Abstract Background/Introduction Although arterial stiffening is related to atherosclerosis progression, its prognostic role in hypertension is not fully elucidated, while augmented left ventricular mass index (LVMI) is linked to adverse outcome. Purpose The aim of the present study was to compare the predictive role of changes in arterial stiffness and LVMI for the incidence of coronary artery disease (CAD) in a cohort of essential hypertensive patients. Methods We followed up 1082 essential hypertensives (mean age 55.9 years, 562 males, office blood pressure (BP)=145/91 mmHg) free of cardiovascular disease for a mean period of 8 years. All subjects had at least one annual visit and at baseline and last visit underwent complete echocardiographic study for estimation of LVMI and measurements of arterial stiffness on the basis of carotid to femoral pulse wave velocity (PWV), by means of a computerized method. The distribution of PWV was split by the median (8.2 m/sec) and accordingly subjects were classified into those with high (n=546) and low values (n=536). Moreover, LV hypertrophy (LVH) was defined as LVMI ≥125 g/m2 in males and LVMI ≥110 g/m2 in females, while CAD was defined as the history of myocardial infarction or significant coronary artery stenosis revealed by angiography or coronary revascularization procedure. Results The incidence of CAD over the follow-up period was 3.5%. Hypertensives who developed CAD (n=38) compared to those without CAD at follow-up (n=1044) had at baseline higher waist circumference (101.7±10.1 vs 96.2±11.6 cm, p=0.004), LVMI (123.9±22.1 vs 105.8±21.3 g/m2, p=0.026), prevalence of LVH (46% vs 25%, p=0.018) and prevalence of high PWV levels (67% vs 40%, p=0.021). No difference was observed between hypertensives with CAD and those without CAD with respect to baseline office BP, serum creatinine and lipid levels (p=NS for all). By univariate Cox regression analysis, it was revealed that changes in PWV levels between baseline and last visit predicted CAD (hazard ratio=1.243, p=0.014). However, in multivariate Cox regression model baseline glomerular filtration rate (hazard ratio=1.029, p=0.015) and changes in LVMI (hazard ratio=1.036, p<0.0001) but not alterations of PWV turned out to be independent predictors of CAD. Conclusions In essential hypertensive patients changes in LVMI predict future development of CAD, whereas PWV alterations exhibit no independent prognostic value. These findings support that LVMI constitutes a superior prognosticator of events than PWV and its estimation is essential in order to improve overall risk stratification in hypertension.


2011 ◽  
Vol 10 (6) ◽  
pp. 105-111 ◽  
Author(s):  
G. A. Chumakova ◽  
O. V. Gritsenko ◽  
N. G. Veselovskaya ◽  
E. V. Vakhromeeva ◽  
A. A. Kozarenko

The assessment and correction of the traditional parameters of atherogenic dyslipidemia are important, but not exclusive methods in the management of atherosclerosis, including coronary artery atherosclerosis. More accurate diagnostic and therapeutic assessment requires the measurement of apolipoprotein (Apo) A, ApoB, and their ratio.Lower ApoB/ApoAI ratio values denote lower levels of cardiovascular risk.


Sign in / Sign up

Export Citation Format

Share Document